The secondary efficacy measurements were the response and remission rates , the Clinical Global Impression - Improvement of Illness ( CGI-I ) score at the end of the study , and the change of the HAMD-@ total score and quality of sleep -LSB- evaluated by the Pittsburgh Sleep Quality Index ( PSQI ) scale -RSB- during the study period .